₹1,207.95-8.05 (-0.66%)
04:00 PM, 13-Dec-2024₹1,208.40-6.20 (-0.51%)
03:49 PM, 13-Dec-2024BSE : 524804
NSE : AUROPHARMA
Sector : Health care
ISIN Code : INE406A01037
Last Updated: 13-Dec-2024 | 04:00 PM IST
Market Cap (₹ Cr) | 70,774 |
Traded Value (₹ Cr) | 4.13 |
Volume (Shares) | 34,151 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,592.55 |
52-Week High Date | 13-Sep-2024 |
52-Week Low (₹) | 959.05 |
52-Week Low Date | 14-Feb-2024 |
All Time High (₹) | 1,592.55 |
All Time High Date | 13-Sep-2024 |
All Time Low (₹) | 0.56 |
All Time Low Date | 20-Nov-1996 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 70,800 |
EPS - TTM (₹) [C] | 62.24 |
P/E Ratio (X) [C] | 19.42 |
Face Value (₹) | 1 |
Latest Dividend (%) | 150.00 |
Latest Dividend Date | 20-Feb-2024 |
Dividend Yield (%) | 0.37 |
Book Value Share (₹) [C] | 527.00 |
P/B Ratio (₹) [C] | 2.29 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Mid-Cap Opportunities Fund (G) | 1647.04 | 1,30,44,847 | 2.17 |
HDFC Mid-Cap Opportunities Fund (IDCW) | 1647.04 | 1,30,44,847 | 2.17 |
HDFC Mid-Cap Opportunities Fund - Direct (IDCW) | 1647.04 | 1,30,44,847 | 2.17 |
HDFC Mid-Cap Opportunities Fund - Direct (G) | 1647.04 | 1,30,44,847 | 2.17 |
Quant Mid Cap Fund (G) | 753.65 | 59,69,000 | 8.43 |
Quant Mid Cap Fund (IDCW) | 753.65 | 59,69,000 | 8.43 |
Quant Mid Cap Fund - Direct (G) | 753.65 | 59,69,000 | 8.43 |
Quant Mid Cap Fund - Direct (IDCW) | 753.65 | 59,69,000 | 8.43 |
Quant Active Fund (G) | 533.23 | 42,23,250 | 5.02 |
Quant Active Fund (IDCW) | 533.23 | 42,23,250 | 5.02 |
Load more
Today's Low/High (₹) | 1,173.10 1,218.85 |
Week Low/High (₹) | 1,173.10 1,259.00 |
Month Low/High (₹) | 1,173.10 1,277.00 |
Year Low/High (₹) | 958.50 1,592.00 |
All time Low/High (₹) | 0.56 1,592.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -3.01% | -3.03% | 0.52 | 0.37% |
1 Month | -3.28% | -3.29% | 5.72 | 5.13% |
3 Month | -22.91% | -22.90% | -0.91 | -2.32% |
6 Month | -3.69% | -3.69% | 6.93 | 5.85% |
1 Year | 16.79% | 16.66% | 18.03 | 18.36% |
3 Year | 74.38% | 74.32% | 40.92 | 42.61% |
Vice Chairman & M.D. : Kambam Nityananda Reddy
Whole-time Director : M Madan Mohan Reddy
Non Executive Director : P V Ramprasad Reddy
Independent Director : Savita Mahajan
Independent Director : Girish Paman Vanvari
Non Executive Director : P Sarath Chandra Reddy
Independent Director : Santanu Mukherjee
Independent Director : Deepali Pant Joshi
Chairman & Independent Directo : M R Kumar
Registered Office: Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet,Hyderabad,Telangana-500038 Ph: 91-40-23736370
1. What's the Aurobindo Pharma Ltd share price today?
Aurobindo Pharma Ltd share price was Rs 1,207.95 at 04:00 PM IST on 13th Dec 2024. Aurobindo Pharma Ltd share price was down by 0.66% from the previous closing price of Rs 1,216.00. Aurobindo Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Aurobindo Pharma Ltd stock?
The performance of the Aurobindo Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Aurobindo Pharma Ltd?
Aurobindo Pharma Ltd has a market capitalisation of Rs 70,774 crore.
4. What is Aurobindo Pharma Ltd's 52-week high/low share price?
The Aurobindo Pharma Ltd’s 52-week high share price is Rs 1,592.55 and 52-week low share price is Rs 959.05.
5. Is the Aurobindo Pharma Ltd profitable?
On a consolidated basis, Aurobindo Pharma Ltd reported a profit of Rs 537.53 crore on a total income of Rs 2,947.25 crore for the quarter ended 2024. For the year ended Sep 2024, Aurobindo Pharma Ltd had posted a profit of Rs 816.95 crore on a total income of Rs 7,932.37 crore.
6. Which are Aurobindo Pharma Ltd’s peers in the Health care sector?
Aurobindo Pharma Ltd’s top 5 peers in the Health care sector are Dr Reddy's Labs, Zydus Lifesci., Lupin, Aurobindo Pharma, Alkem Lab, Abbott India, Glenmark Pharma..
7. Who owns how much in Aurobindo Pharma Ltd?
Key changes to the Aurobindo Pharma Ltd shareholding are as follows: